免疫健康一直是膳食补充剂行业的支柱，但去年新冠肺炎疫情创造了前所未有的

Immune health has always been the mainstay of the dietary supplement industry, but last year the new crown pneumonia epidemic created unprecedented demand. According to a consumer survey conducted by Innova Market Insights in March 2020, the consumption of immunity-enhancing products in Asia and South America has seen particularly strong growth. Over 70% of consumers in India and Indonesia are choosing more immune system enhancement products, and nearly 40% in the United States. At the same time, the proportion of consumers in Germany and the Netherlands turning to healthy consumption has increased in different proportions. The epidemic has brought challenges to the industry. Many new immune products have emerged on the market. Consumers are becoming more and more interested in edible and medicinal fungi. The development of mushroom products will also become the focus of immune health research and development.

Immune health has been a pillar of the dietary supplement industry, but last year's outbreak of new crown pneumonia created unprecedented demand. A consumer survey conducted by Innova Market Insights in March 2020 showed particularly strong growth in consumption of immune-enhancing products in Asia and South America. More than 70 percent of Indian and Indonesian consumers are opting for more immune system-boosting products, and nearly 40 percent in the United States. At the same time, consumers such as Germany and the Netherlands have increased in proportion to healthy consumption. The outbreak has brought challenges to the industry, many new immune products have emerged in the market, consumers are becoming more and more interested in medicinal bacteria, mushroom product development will also become the focus of immune health research and development

Hitherto unknown, novel coronavirus pneumonia has created unprecedented demand for immunization. A consumer survey conducted by innova market insights in March 2020 showed a particularly strong growth in consumption of immunity enhancing products in Asia and South America. More than 70% of Indian and Indonesian consumers are choosing more immune system enhancing products, compared with nearly 40% in the United States. At the same time, the proportion of consumers in Germany and the Netherlands turning to health consumption has increased in different proportions. The epidemic has brought challenges to the industry. Many new immune products have emerged in the market. Consumers are more and more interested in edible and medicinal fungi. The development of mushroom products will also become the focus of immune health research and development<br>